Search Results
Keyword：EU
Mangoceuticals to Merge with Nuclea to Advance Morpheus Microreactor to Market
Mangoceuticals announced on July 30 that it has signed a definitive business combination agreement with advanced nuclear technology company Nuclea Energy Inc., aiming to bring the latter's Morpheus microreactor to the public capital markets. Nuclea was founded in August 2023 and is headquartered in Mississauga, Ontario, Canada, focusing on the development of lead-cooled, factory-fabricated micro-modular reactors. Under the agreement, a newly formed subsidiary of Mangoceuticals will merge with Nuclea, and the combined company will operate as an indirect wholly owned subsidiary of Mangoceuticals. Upon completion of the transaction, holders of Nuclea common shares will receive...
2026-07-31
Europe Completes Manufacturing of JT-60SA Pellet Centrifuge Accelerator
The European Fusion Energy Organization (F4E) recently announced progress on key components of a new pellet injection system for the upgrade of the JT-60SA device. The centrifuge accelerator, manufactured by Sener, has been completed and delivered to the Max Planck Institute for Plasma Physics (IPP). It will subsequently be integrated with other components of the pellet injection system and undergo testing. The operation of fusion devices relies on the continuous supply of hydrogen isotope fuel. In devices such as JT-60SA and the International Thermonuclear Experimental Reactor (ITER), the pellet injection system is used to fuel the plasma and assist in controlling plasma instabilities. The system typically consists of three parts: preparation...
2026-07-29
Urenco Isotopes Collaborates on EMIS Test Facility to Strengthen Europe's Enriched Lanthanide Isotope Supply Chain
On July 28, 2026, Urenco Isotopes announced a collaboration with RI Research Instruments to advance the construction of a dedicated Electromagnetic Isotope Separation (EMIS) test facility, aiming to strengthen the future European supply chain for enriched lanthanide elements and meet the growing demand for high-purity stable isotopes in scientific research and potential medical isotope applications. Lanthanides are rare earth metals, and their isotopes may be used in the future for cancer diagnosis and treatment. Currently, reliable sources of high-purity lanthanide stable isotopes remain limited, with the supply chain concentrated among a few producers, and Europe's local supply capacity is relatively insufficient. Under the collaboration arrangement, RI Research Instruments...
2026-07-29
EU Releases 2026–2027 Nuclear Research and Training Work Programme: Focusing on Safety, Innovation, and Capacity Building
Recently, the European Commission officially released the "2026-2027 European Atomic Energy Community (Euratom) Research and Training Work Programme" (hereinafter referred to as the Euratom Programme). This programme is a continuation and deepening of the Euratom work plan for 2021-2025, setting out the strategic directions, priorities, and funding actions for nuclear research in the next two years. This article systematically reviews the core content of the Euratom Programme, providing a detailed introduction from multiple dimensions, including the strategic framework, annual guidelines, specific actions in various research areas, other supporting measures, and budget arrangements, aiming to offer a comprehensive reference for domestic nuclear safety regulation and technical support work. Overall Strategy...
2026-07-29
Hefei establishes a new joint laboratory for fusion reactor material irradiation and evaluation, driving the coordinated development of the nuclear fusion industry.
Recently, the Joint Laboratory for Fusion Reactor Material Irradiation and Evaluation—co-established by the Institute of Plasma Physics (Hefei Institutes of Physical Science, Chinese Academy of Sciences) and the Institute of High Energy Physics (Chinese A
2026-07-27
The U.S. Department of Energy conditionally allocates HALEU fuel to NASA and Radiant.
On July 23, the U.S. Department of Energy (DOE) announced a conditional commitment to provide High-Assay Low-Enriched Uranium (HALEU) to NASA and Radiant Industries to meet near-term fuel needs. This marks the third round of HALEU allocations; the materia
2026-07-27
Kazakhstan advances the use of radiation technology for agricultural preservation and advanced wastewater treatment.
Sayabek Sakhiyev, Director of the Institute of Nuclear Physics of Kazakhstan, recently stated that radiation technology holds promise for helping Kazakhstan reduce post-harvest losses, extend the shelf life of agricultural products, and facilitate advance
2026-07-27
China and Russia Discuss Cooperation on Non-Energy Applications of Nuclear Technology in Beijing
On July 24, Rosatom hosted a Russian-Chinese business matchmaking event in Beijing, focusing on cooperation in the non-energy applications of nuclear technology. Held at the Trade Representation of the Russian Federation in China, the event was attended b
2026-07-27
The U.S. Department of Energy conditionally allocates HALEU fuel to NASA and Radiant.
On July 23, the U.S. Department of Energy (DOE) announced a conditional commitment to provide High-Assay Low-Enriched Uranium (HALEU) to NASA and Radiant Industries to meet near-term fuel needs. This marks the third round of HALEU allocations; the materia
2026-07-27
X-energy Joins Project Prometheus, Supporting AI-Driven Nuclear Energy R&D with Xe-100 and TRISO-X
On July 22, X-energy announced it had become a founding member of the "Prometheus" initiative and would participate as a Tier 1 partner. Led by Idaho National Laboratory (INL), NVIDIA, and Amazon Web Services (AWS), the initiative aims to levera
2026-07-23